Indication
Cerebrotendinous xanthomatosis
Cerebrotendinous xanthomatosis is a rare autosomal recessive lipid storage disorder of bile acid synthesis caused by pathogenic variants in the *CYP27A1* gene. Read more about Cerebrotendinous xanthomatosis
2 drugs 2 manufacturers
Drugs that treat it
Common Cerebrotendinous xanthomatosis therapies.
CTEXLI (chenodiol)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCerebrotendinous xanthomatosis is a rare autosomal recessive lipid storage disorder of bile acid synthesis caused by pathogenic variants in the *CYP27A1* gene.
This genetic defect leads to a deficiency in the mitochondrial enzyme sterol 27-hydroxylase, impairing primary bile acid production and driving systemic accumulation of cholestanol and cholesterol.
The disease primarily affects the central nervous system, eyes, gastrointestinal tract, and musculoskeletal structures, classically manifesting with infantile-onset chronic diarrhea, juvenile-onset bilateral cataracts, and tendon xanthomas typically involving the Achilles tendon.
Progressive pathophysiologic accumulation leads to severe adult-onset neurologic deterioration, characterized by ataxia, spasticity, peripheral neuropathy, dystonia, psychiatric disturbances, and cognitive decline.
- nih.gov
Cerebrotendinous xanthomatosis is a rare autosomal recessive lipid storage disorder of bile acid synthesis caused by pathogenic variants in the *CYP27A1* gene
- frontiersin.org
Cerebrotendinous xanthomatosis is a rare autosomal recessive lipid storage disorder of bile acid synthesis caused by pathogenic variants in the *CYP27A1* gene This genetic defect leads to a deficiency in the mitochondrial enzyme sterol 27-hydroxylase, impairing primary bile acid production and driving systemic accumulation of cholestanol and cholesterol
- rarediseases.org
This genetic defect leads to a deficiency in the mitochondrial enzyme sterol 27-hydroxylase, impairing primary bile acid production and driving systemic accumulation of cholestanol and cholesterol
- nih.gov
The disease primarily affects the central nervous system, eyes, gastrointestinal tract, and musculoskeletal structures, classically manifesting with infantile-onset chronic diarrhea, juvenile-onset bilateral cataracts, and tendon xanthomas typically involving the Achilles tendon
- nih.gov
The disease primarily affects the central nervous system, eyes, gastrointestinal tract, and musculoskeletal structures, classically manifesting with infantile-onset chronic diarrhea, juvenile-onset bilateral cataracts, and tendon xanthomas typically involving the Achilles tendon Progressive pathophysiologic accumulation leads to severe adult-onset neurologic deterioration, characterized by ataxia, spasticity, peripheral neuropathy, dystonia, psychiatric disturbances, and cognitive decline
- tmc.edu
Progressive pathophysiologic accumulation leads to severe adult-onset neurologic deterioration, characterized by ataxia, spasticity, peripheral neuropathy, dystonia, psychiatric disturbances, and cognitive decline
Personalize your experience
Follow Cerebrotendinous xanthomatosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.